KatieB Posted May 31, 2016 Share Posted May 31, 2016 KRAS Clinical Trial information: This trial is designed to evaluate how safe and effective the study drug known as abemaciclib is in participants with lung cancer. Specifically for people who have a confirmed diagnosis of stage IV non-small cell lung cancer (NSCLC) with a KRAS mutation and who have already received prior chemotherapy. http://www.lillytrialguide.com/juniper3 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.